VC firm

Privilege Ventures

Kingmaker Tier

Kingmaker Tier: 84 out of 100

Biotech & therapeutics
Care delivery & digital health
Health IT
Medical devices & diagnostics
Mental health & wellness
Other
Women's & family health
Seed
Deeptech
CH
Europe
VC
B2B

Investor type: VC
Investing status: Activeas of 2026-09-17Source (opens in a new tab)
Headquarters: Switzerland
Founded: 2021

Open relationship map

Claim, correct or request removal

Record updated 17 September 2026

About

Privilège Ventures is a Swiss, FINMA-authorized early-stage investor supporting ambitious founders in HealthTech, MedTech, and Longevity, where breakthrough science and deep technology are redefining the future of human health.

Investment approach

Thesis: We invest with conviction in innovative technologies with the highest potential to improve people’s lives. Our strategy runs on two engines: backing the winners in our portfolio as they mature and continuing to source the next generation of champions to join them.Source (opens in a new tab)
Investing status notes: continuing to source the next generation of champions to join them.

Programs

Newsletter: newsletter (opens in a new tab)

Relationships

VC Catalog has relationship data for this record. Sign in with Google to explore it on the interactive map.